BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32077477)

  • 1. Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial.
    Giustino G; Tijssen J; Windecker S; Dangas G
    Cardiovasc Res; 2020 Mar; 116(3):e39-e41. PubMed ID: 32077477
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of stroke after transcatheter prosthetic aortic valve implant with aortic bioprosthesis: subclinical thrombosis and possible therapeutic implications.
    Di Pasquale G; Coutsoumbas GV; Zagnoni S
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e46-e49. PubMed ID: 29045310
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report.
    Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Very Early Thrombosis of SAPIEN 3 Valve with Direct Oral Anticoagulant Therapy.
    Ruparelia N; Panoulas VF; Frame A; Sutaria N; Ariff B; Gopalan D; Chukwuemeka A; Mikhail GW; Malik IS
    J Heart Valve Dis; 2016 Mar; 25(2):211-213. PubMed ID: 27989069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAVR and Thrombosis.
    Trantalis G; Toutouzas K; Latsios G; Synetos A; Brili S; Logitsi D; Penesopoulou V; Tousoulis D
    JACC Cardiovasc Imaging; 2017 Jan; 10(1):86-87. PubMed ID: 28057223
    [No Abstract]   [Full Text] [Related]  

  • 7. Asymmetric Ventricular Foreshortening of SAPIEN-3 Transcatheter Heart Valve Associated With Leaflet Subclinical Thrombosis.
    Vera-Urquiza R; Tirado-Conte G; Armijo G; Jimenez-Quevedo P; Nombela-Franco L
    JACC Cardiovasc Interv; 2019 Jan; 12(1):100-102. PubMed ID: 30553707
    [No Abstract]   [Full Text] [Related]  

  • 8. Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial.
    Sulzgruber P; Hammer A; Niessner A
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1239-1241. PubMed ID: 35699869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Anticoagulation After Tissue Aortic and Mitral Valve Replacement.
    Moonsamy P; Mohan N; Melnitchouk S
    Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):197-201. PubMed ID: 31870926
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience.
    Gurevich S; Oestreich B; Kelly RF; Mbai M; Bertog S; Yannopoulos D; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):621-625. PubMed ID: 29276174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of apixaban versus aspirin for the prevention of latent bioprosthetic aortic valve thrombosis: study protocol for a prospective randomized trial.
    Kopjar T; Gasparovic H; Paar MH; Lovric D; Cerina P; Tokic T; Milicic D
    Trials; 2024 May; 25(1):324. PubMed ID: 38755709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    De Backer O; Dangas GD; Jilaihawi H; Leipsic JA; Terkelsen CJ; Makkar R; Kini AS; Veien KT; Abdel-Wahab M; Kim WK; Balan P; Van Mieghem N; Mathiassen ON; Jeger RV; Arnold M; Mehran R; Guimarães AHC; Nørgaard BL; Kofoed KF; Blanke P; Windecker S; Søndergaard L;
    N Engl J Med; 2020 Jan; 382(2):130-139. PubMed ID: 31733182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulant Use After Transcatheter Aortic Valve Replacement: A Case Series.
    Hendricks AK; Nei SD; Greason KL; Scott RA
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):41-44. PubMed ID: 31633585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
    Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
    Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.
    Reyes M; Reardon MJ
    Methodist Debakey Cardiovasc J; 2017; 13(3):126-131. PubMed ID: 29743997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban in peripheral artery disease: The new kid on the block?
    Hussain MA; Verma S; Al-Omran M
    J Vasc Surg; 2018 Mar; 67(3):985-986. PubMed ID: 29477208
    [No Abstract]   [Full Text] [Related]  

  • 18. The difficult balance between thrombosis and bleeding after transcatheter aortic valve replacement: A translational review.
    Trimaille A; Marchandot B; Park SH; Schini-Kerth V; Morel O
    Arch Cardiovasc Dis; 2020 Apr; 113(4):263-275. PubMed ID: 32057662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent Thrombosis During TAVR.
    Takiguchi H; Yamaji K; Shirai S; Ando K
    JACC Cardiovasc Interv; 2020 Mar; 13(6):e45-e47. PubMed ID: 31786221
    [No Abstract]   [Full Text] [Related]  

  • 20. Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy.
    Montalescot G; Redheuil A; Vincent F; Desch S; De Benedictis M; Eltchaninoff H; Trenk D; Serfaty JM; Charpentier E; Bouazizi K; Prigent M; Guedeney P; Salloum T; Berti S; Cequier A; Lefèvre T; Leprince P; Silvain J; Van Belle E; Neumann FJ; Portal JJ; Vicaut E; Collet JP;
    JACC Cardiovasc Interv; 2022 Sep; 15(18):1794-1804. PubMed ID: 36137682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.